136 related articles for article (PubMed ID: 34004593)
21. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Li ZB; Chen K; Chen X
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
[TBL] [Abstract][Full Text] [Related]
22. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
23. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079
[TBL] [Abstract][Full Text] [Related]
24. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
[TBL] [Abstract][Full Text] [Related]
25. Enhanced active targeting via cooperative binding of ligands on liposomes to target receptors.
Sugiyama T; Asai T; Nedachi YM; Katanasaka Y; Shimizu K; Maeda N; Oku N
PLoS One; 2013; 8(6):e67550. PubMed ID: 23840738
[TBL] [Abstract][Full Text] [Related]
26.
Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ
Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136
[TBL] [Abstract][Full Text] [Related]
27. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
[No Abstract] [Full Text] [Related]
28. [
Lang CI; Döring P; Gäbel R; Vasudevan P; Lemcke H; Müller P; Stenzel J; Lindner T; Joksch M; Kurth J; Bergner C; Wester HJ; Ince H; Steinhoff G; Vollmar B; David R; Krause BJ
Cells; 2020 May; 9(6):. PubMed ID: 32486211
[TBL] [Abstract][Full Text] [Related]
29. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK).
Simeček J; Notni J; Kapp TG; Kessler H; Wester HJ
Mol Pharm; 2014 May; 11(5):1687-95. PubMed ID: 24669840
[TBL] [Abstract][Full Text] [Related]
30. Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?
Haubner R
Eur J Nucl Med Mol Imaging; 2006 Jul; 33 Suppl 1():54-63. PubMed ID: 16791598
[TBL] [Abstract][Full Text] [Related]
31. Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging.
Ma MT; Neels OC; Denoyer D; Roselt P; Karas JA; Scanlon DB; White JM; Hicks RJ; Donnelly PS
Bioconjug Chem; 2011 Oct; 22(10):2093-103. PubMed ID: 21877750
[TBL] [Abstract][Full Text] [Related]
32. PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells.
Cai M; Ren L; Yin X; Guo Z; Li Y; He T; Tang Y; Long T; Liu Y; Liu G; Zhang X; Hu S
Amino Acids; 2016 Mar; 48(3):811-820. PubMed ID: 26592497
[TBL] [Abstract][Full Text] [Related]
33. Radiosynthesis, Biological Evaluation, and Preclinical Study of a
Pirooznia N; Abdi K; Beiki D; Emami F; Arab SS; Sabzevari O; Pakdin-Parizi Z; Geramifar P
Contrast Media Mol Imaging; 2020; 2020():8421657. PubMed ID: 32292304
[TBL] [Abstract][Full Text] [Related]
34.
Farkasinszky G; Dénes N; Rácz S; Kis A; Péliné JS; Opposits G; Veres G; Balkay L; Kertész I; Mező G; Hunyadi J; Trencsényi G
In Vivo; 2022; 36(2):657-666. PubMed ID: 35241519
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Preclinical Evaluation of a
Li H; Yuan L; Long Y; Fang H; Li M; Liu Q; Xia X; Qin C; Zhang Y; Lan X; Gai Y
Mol Pharm; 2020 Aug; 17(8):3000-3008. PubMed ID: 32544337
[TBL] [Abstract][Full Text] [Related]
36. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928
[TBL] [Abstract][Full Text] [Related]
37.
Zhao ZQ; Ji S; Li XY; Fang W; Liu S
Appl Radiat Isot; 2019 Jun; 148():168-177. PubMed ID: 30959354
[No Abstract] [Full Text] [Related]
38. Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes.
Floresta G; Memdouh S; Pham T; Ma MT; Blower PJ; Hider RC; Abbate V; Cilibrizzi A
Dalton Trans; 2022 Aug; 51(34):12796-12803. PubMed ID: 35972045
[TBL] [Abstract][Full Text] [Related]
39. Integrin αvβ3 as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter (68)Ga-Labeled DOTA-Arginine-Glycine-Aspartic Acid (RGD) Ligand.
Vatsa R; Bhusari P; Kumar S; Chakraborty S; Dash A; Singh G; Dhawan DK; Shukla J; Mittal BR
Cancer Biother Radiopharm; 2015 Jun; 30(5):217-24. PubMed ID: 26083951
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Characterization of 4
Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
